Long-term outcomes of early-onset wheeze and asthma.
Evidence from longitudinal cohort studies demonstrates that wheezing that begins in early life and continues into the school years generally persists into adulthood. This persistent wheezing is associated with lung function deficits and airways hyperresponsiveness that appear to be established in the first few years of life. Allergic sensitization early in life, early-life infection with rhinovirus, or colonization with any of a number of bacteria have been associated with increased risk of persistent wheeze. Early life, whether in utero or in the first few years of life, presents a window of vulnerability during which airway injury results in persistent airways dysfunction. Available data further suggest that a second such window of vulnerability might be present in the preadolescent and adolescent years. Lung function growth patterns established by age 6 years generally continue into early adulthood to middle adulthood, typically leaving groups of subjects with wheezing that persists into or relapses during adulthood with a mean FEV(1) of about 10% of predicted value less than their peers who do not wheeze. Subgroups of patients with persistent asthma, however, can have progressive decreases in lung function and enter adulthood with even lower lung function. The concern exists that these deficits in lung function apparent in early adulthood might put subjects at risk for the later development of chronic obstructive pulmonary disease.
Department of Pediatrics and the Arizona Respiratory Center, University of Arizona College of Medicine, Tucson, AZ 85724, USA. roni.grad@gmail.com
Roni
R
Grad
Wayne J
WJ
Morgan
D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D001249:Asthma / Q000150:complications / Q000276:immunology* / Q000473:pathology; D016535:Bronchial Hyperreactivity / Q000150:complications / Q000276:immunology / Q000473:pathology; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D011379:Prognosis; D029424:Pulmonary Disease, Chronic Obstructive / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D012129:Respiratory Function Tests; D012135:Respiratory Sounds / Q000276:immunology*; D012137:Respiratory System / Q000276:immunology* / Q000382:microbiology / Q000821:virology; D012141:Respiratory Tract Infections / Q000150:complications / Q000276:immunology / Q000473:pathology; D012307:Risk Factors